Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.82
+0.34 (5.25%)
At close: Feb 2, 2026, 4:00 PM EST
6.69
-0.13 (-1.91%)
After-hours: Feb 2, 2026, 7:29 PM EST
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $343.67 million as of February 2, 2026. Its market cap has increased by 128.05% in one year.
Market Cap
343.67M
Enterprise Value
290.33M
1-Year Change
128.05%
Ranking
Category
Stock Price
$6.82
Market Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has increased from $280.60M to $343.67M, an increase of 22.48%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 326.50M | 8.91% |
| Dec 31, 2025 | 299.80M | 100.27% |
| Dec 31, 2024 | 149.70M | -27.33% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
| Apr 24, 2012 | 280.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 338.18M |
| Foghorn Therapeutics | 334.50M |
| Atea Pharmaceuticals | 331.26M |
| Cybin | 330.36M |
| X4 Pharmaceuticals | 323.52M |
| Aldeyra Therapeutics | 322.47M |
| Candel Therapeutics | 320.61M |
| XOMA Royalty | 317.75M |